It has been demonstrated that TGF-β exerts physiological effects on embryonic development, cardiac development and cellular growth; however, dysregulated TGF-β signaling is associated with a host of unwanted pathologic conditions, such as fibrosis, cardiac hypertrophy and inflammation [71,114,115,116]. The gene discussed is TGFB1; the disease is cardiac hypertrophy.